20/20 Biolabs Inc. (AIDX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

20/20 Biolabs Inc. (AIDX) operates in the Healthcare sector, specifically the Medical - Care Facilities industry, with a market capitalization near $3.1M, listed on NASDAQ, employing roughly 14 people, carrying a beta of 1.80 to the broader market. 20/20 GeneSystems, Inc. Led by Jonathan Cohen, public since 2026-02-19.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for AIDX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →